Cumberland Pharma Plans Ifetroban NDA for DMD
Cumberland Pharmaceuticals has announced plans to file New Drug Application (NDA) for ifetroban DMD program.
Ifetroban | 28/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy